诊断成像市场概况、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPHE100001107
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Diagnostic Imaging Market Trends, Share, and Growth by 2031

Buy Now

诊断成像市场规模预计将从 2023 年的 399.3 亿美元增至 2031 年的 601.7 亿美元。预计 2023-2031 年期间市场复合年增长率5.26%。诊断成像设备中人工智能 (AI) 和分析的日益普及可能仍将是市场的主要趋势。

诊断成像市场分析

诊断成像描述了各种技术,用于直观地表示人体的不同组织和器官,以确定疾病或损伤的原因、确认诊断并监测治疗反应。各种机器和技术,例如 X 射线、计算机断层扫描 (CT)、正电子发射断层扫描 (PET)、磁共振成像 (MRI)、单光子发射计算机断层扫描 ( SPECT )、数字乳房 X 线摄影和诊断超声检查,都可以生成身体内结构和活动的图像。许多成像测试都是非侵入性、简单且无痛的。但是,有些可能需要您长时间静止在机器内,这可能会有些不舒服。此外,某些测试涉及少量辐射暴露。慢性病患病率的增加是市场增长的主要驱动因素。此外,医疗诊断领域的新发展也促进了预测期内的市场增长。

诊断成像市场概况

2023 年,亚太地区预计将以全球诊断成像市场最高的复合年增长率增长。由于中国、日本和印度等国家的发展,亚太地区诊断成像市场预计将大幅增长。根据 2023 年 9 月美国国家医学图书馆 ( NLM ) 发表的一篇文章,高知县每 100,000 人口的 CT 扫描仪数量最多,而东京都的医院 CT 扫描仪数量最多。因此,亚太地区的市场受到来自多个亚洲国家的国际参与者不断增长的投资的推动。因此,该地区对诊断成像市场参与者在预测期内具有巨大的增长潜力。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

诊断成像市场:

诊断成像市场
  • Diagnostic Imaging Market
    复合年增长率(2023 - 2031)
    5.26%
  • 2023 年市场规模
    399.3 亿美元
  • 2031年市场规模
    601.7亿美元

市场动态

增长动力
  • 慢性病患病率上升,对高效诊断测试和工具的需求增加
  • 诊断领域的技术进步促进了市场的增长
未来的趋势
  • 人工智能(AI)和分析在诊断成像设备中的应用
机会
  • 政府支持和举措开拓增长空间

关键人物;主力;重要一员

  • 通用电气公司
  • 西门子医疗
  • 荷兰皇家飞利浦公司
  • 卡尔史托斯股份两合公司
  • 富士胶片控股株式会社
  • 佳能公司
  • 霍洛吉奇公司
  • 锐珂医疗公司
  • 史赛克公司
  • 奥林巴斯公司

区域概况

Diagnostic Imaging Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Diagnostic Imaging Market情态
  • X 射线
  • CT
  • 内窥镜检查
  • 超声波
  • 磁共振成像
  • 核成像
  • 乳房X光检查
Diagnostic Imaging Market应用
  • 心脏病学
  • 肿瘤学
  • 神经病学
  • 骨科
  • 胃肠病学
  • 妇产科
Diagnostic Imaging Market最终用户
  • 医院和诊所
  • 诊断影像中心
  • 门诊手术中心
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

诊断成像市场驱动因素和机遇

诊断成像技术进步利好市场

正如世界卫生组织 (WHO) 所强调的那样,诊断成像技术发展迅速,通过支持各种疾病的诊断和治疗,在医疗保健中发挥着至关重要的作用。诊断成像服务包括确认、评估和记录许多疾病的病程,以最终得出治疗反应。根据 AdventHealth University 于 2021 年 10 月发表的一篇文章,近年来,数字射线照相术取得了许多进步。这些进步包括人工智能辅助 X 射线解释、双能量成像、计算机辅助诊断、断层合成、自动图像拼接和数字移动射线照相术。这些进步提高了图像质量,最终增强了患者护理并支持更好的患者治疗结果。此外,使用数字射线照相术减少了重拍的需要,从而降低了辐射暴露。

疾病诊断成像技术的进步促进了诊断成像市场的增长。

政府举措带来增长机遇

政府在全世界范围内采购、定价和分销医疗设备方面发挥着至关重要的作用。各国政府采取各种举措发展医疗基础设施,并通过资助开设新的医疗机构,专注于提供安全且具有成本效益的医疗产品。例如,在英国,国家医疗服务体系旨在通过具有成本效益的方式解决患者未满足的医疗需求,以促进该国的经济增长。此外,由于 2020 年加拿大缺乏私人资金,政府向医院支付了每位患者每次扫描 1,400 美元的费用。

此外,世卫组织和联合国儿童基金会 (UNICEF) 等非营利监管机构与制造商合作,开发有效的解决方案,旨在改善偏远地区的诊断服务。此外,这些组织还提供有关成像技术使用和管理的培训计划,更加注重患者安全。例如,2022 年 2 月,西门子医疗与联合国儿童基金会合作,支持改善撒哈拉以南非洲地区诊断技术的医疗保健服务。

上述因素为促进诊断成像市场的增长提供了有利可图的机会。

诊断成像市场报告细分分析

有助于得出诊断成像市场分析的关键部分是模式、应用和最终用户。

  • 诊断成像市场根据方式细分为 X 射线、CT、内窥镜检查、超声、MRI、核成像、乳房 X 线摄影等。ELISA 测试细分市场在 2023 年占据了最大的市场份额。
  • 根据应用,市场细分为心脏病学、肿瘤学、神经病学、骨科、胃肠病学、妇产科等。禽流感领域在 2023 年占据了最大的市场份额。
  • 根据最终用户,市场细分为医院和诊所、诊断成像中心、门诊手术中心等。医院和诊所部分在 2023 年占据了最大的市场份额。

诊断成像市场份额按地区分析

诊断成像市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美拥有下一代测序市场的最大市场份额。北美的诊断成像市场基于美国、加拿大和墨西哥进行分析。预计美国将在 2023 年主导北美诊断成像市场。由于成像模式的创新推出和监管机构的批准,美国的诊断成像利用率很高。例如,2021 年 9 月,FDA 宣布批准计算机断层扫描 (CT) 成像的第一个重大技术进步。该设备利用光子计数探测器的新兴 CT 技术来测量穿过患者身体的每一个 X 射线。FDA 还审查了西门子于 2021 年制造的新型诊断成像设备“NAEOTOM Alpha”。成像模式的这种技术进步加速了美国诊断成像的普及。

此外,随着美国人口老龄化,用于诊断、检测和治疗老年人群常见的许多慢性健康状况和疾病的诊断成像技术的需求预计将高速增长。

因此,北美市场的增长源于该地区对诊断成像技术的需求不断增长。

诊断成像市场报告范围

报告属性细节
2023 年的市场规模399.3亿美元
2031 年市场规模601.7亿美元
全球复合年增长率(2023 - 2031)5.26%
历史数据2021-2022
预测期2024-2031
涵盖的领域按方式
  • X 射线
  • CT
  • 内窥镜检查
  • 超声波
  • 磁共振成像
  • 核成像
  • 乳房X光检查
按应用
  • 心脏病学
  • 肿瘤学
  • 神经病学
  • 骨科
  • 胃肠病学
  • 妇产科
按最终用户
  • 医院和诊所
  • 诊断影像中心
  • 门诊手术中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 通用电气公司
  • 西门子医疗
  • 荷兰皇家飞利浦公司
  • 卡尔史托斯股份两合公司
  • 富士胶片控股株式会社
  • 佳能公司
  • 霍洛吉奇公司
  • 锐珂医疗公司
  • 史赛克公司
  • 奥林巴斯公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

诊断成像市场新闻和最新发展

通过收集来自一手和二手研究的定性和定量数据来评估诊断成像市场,其中包括重要的公司出版物、协会数据和数据库。诊断成像市场的一些发展如下所列:

  • Wipro GE Healthcare 宣布推出其下一代 Revolution Aspire CT(计算机断层扫描)扫描仪。Revolution Aspire 是一款先进的成像解决方案,由新成立的 Wipro GE 医疗设备制造工厂在印度端到端设计和制造,符合“Atmanirbhar Bharat”计划。CT 系统配备了更高的成像智能,可在诊断疾病和异常时提高临床信心。(来源:GE HealthCare,新闻稿,2022 年)
  • Zionexa 是一家领先的体内肿瘤学和神经学生物标志物创新公司,其产品有助于实现更加个性化的医疗保健,现已被 GE Healthcare 收购。Cerianna(氟雌二醇 F-18)是一种经 FDA 批准的 PET 成像剂,可作为活检的辅助手段,用于检测雌激素受体 (ER) 阳性病变,以帮助为复发性或转移性乳腺癌患者提供治疗选择信息,该公司正在扩大其规模。(来源:GE HealthCare,新闻稿,2021 年)

诊断成像市场报告覆盖范围和交付成果

“诊断成像市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 诊断成像市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 诊断成像市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 诊断成像市场分析涵盖主要市场趋势、全球和区域框架、重要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及诊断成像市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the diagnostic imaging market in 2023?

North America dominated the diagnostic imaging market in 2023.

What are the driving factors impacting the diagnostic imaging market?

Factors rising zoonotic disease cases and technological advancements in diagnostics are driving the Diagnostic Imaging market growth.

What are the future trends of the diagnostic imaging market?

Adoption of farm-side diagnostic poultry platform is a future trend in the market.

Which are the leading players operating in the diagnostic imaging market?

General Electric Company, Siemens Healthineers, Koninklijke Philips N.V., 13.4 KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, Canon Inc, Hologic Inc, Carestream Health Inc., Stryker Corporation, Olympus Corporation are some leading players operating in the diagnostic imaging market.

What would be the estimated value of the diagnostic imaging market by 2031?

The Diagnostic Imaging market is estimated to reach US$ 934.57 million by 2031.

What is the expected CAGR of the diagnostic imaging market?

The Diagnostic Imaging market is anticipated to grow at a CAGR of 11.20% during 2023-2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..